111In-PEP09239

N/A

Report date: 2025/11/11 17:59:56

Base Information

Drug Name111In-PEP09239

Drug Alias Name111In-PEP09239[111In]PEP09239

ClassificationRadiation-emitting products > Nuclides > Indium > 111InRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 binders

TargetsReceptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySweden

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesKth Royal Institute Of Technology

China Registration ClassN/A

Develop Information

Active CompaniesKth Royal Institute Of Technology

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A